Lower SHBG levels; higher free testosterone and LH levels. Suggestive of hypothalamic up-regulation in response to lower estrogen levels. Postulated nutritional aromatase inhibitor and no increased risk factor for BC development. Here, CYP19A1 is linked to breast cancer.